Cord blood cells aim to break transfusion dependence in aplastic anemia
NCT ID NCT07499102
First seen Apr 01, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This study tests a new treatment called CK0801 for adults with aplastic anemia who still need blood transfusions after standard treatments. CK0801 uses immune cells from donated cord blood to help the body make its own blood cells again. The goal is to see if it is safe and can reduce or stop the need for transfusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.